PCR: Revenue and profit fell sharply in 2025 amid weak demand and rising competition

About this update from Pcc Rokita Spolka Akcyjna

In 2025, the Group saw a 7.5% drop in revenue and a 57% decline in net profit, mainly due to weak demand and strong Asian competition in key segments. Despite higher investment and stable sales volumes, EBITDA fell 25% year-over-year, with energy and regulatory risks remaining high.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Pcc Rokita Spolka Akcyjna